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a b s t r a c t
In spite of recent advances regarding equipment and surgical techniques in colorectal sur-
gery, rates of anastomotic dehiscence (AD) have remained stable throughout the years. 
The development of products to protect anastomosis aiming the reduction of AD rates has 
shown to be promising. Human fi brinogen and thrombin patch (HFTP - Tachosil®) have 
been used in experimental studies in animals and small case series in humans, with prom-
ising results. In this study, the authors describe the technique of HFTP use in details, aiming 
the protection of colorectal anastomosis, and retrospectively demonstrate the preliminary 
results in a pilot case series. HFTP was used in 4 patients submitted to conventional sur-
gery. The procedures performed were: left colon resection, segmental colectomy (both for 
colorectal cancer), enteral anastomosis for fi stula closure and right ileocolectomy. Anasto-
motic healing and absence of complications were observed in 3 patients, and the patient 
submitted to right ileocolectomy developed AD and died after reoperation. The use of HFTP 
is safe and can be indicated in selected cases. However, AD can occur even after the use of 
this strategy. Randomized controlled trials with larger samples of patients are needed in 
order to properly defi ne the real benefi ts of this strategy in dehiscence prevention
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Membrana de fi brinogênio e trombina humanos para proteção extra-
luminal de anastomoses intestinais
Palavras-chave:
Anastomose cirúrgica
Cirurgia colorretal
Deiscência da ferida operatória
r e s u m o
Apesar dos avanços em equipamentos e técnica cirúrgica na cirurgia colorretal, os índices 
de deiscência de anastomose (DA) tem permanecido estáveis nos últimos anos. O desen-
volvimento de produtos que visam proteção das anastomoses para redução das taxas de 
DA tem se mostrado promissor. A membrana de fi brinogênio e trombina humanos (MFTH) 
vem sendo utilizada em estudos experimentais e em pequenas séries de casos em huma-
nos, com resultados promissores. Neste artigo os autores detalham a  descrição técnica da 
utilização da MFTH na proteção de anastomoses colorretais, e demonstram os resultados 
preliminares em uma série de casos inicial, de forma retrospectiva. A MFTH foi utilizada 
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em 4 pacientes para proteção das anastomoses, todos operados por via de acesso conven-
cional. Os procedimentos realizados foram: retossigmoidectomia abdominal, colectomia 
segmentar, enteroanastomose para fechamento de fístula enteral e ileocolectomia direita. 
Observou-se cicatrização das anastomoses  em 3 casos, e DA com necessidade de reope-
ração e óbito no paciente submetido a ileocolectomia direita. A utilização da MFTH para 
proteção de anastomoses colorretais é segura, e pode ser utilizada em casos selecionados. 
DA pode ocorrer mesmo com a utilização da membrana. Aguarda-se estudos randomizados 
e controlados com maior amostragem de pacientes para se avaliar o real papel dessa estra-
tégia na prevenção da deiscência.
Introduction
Although in recent years surgeons have enjoyed greater suc-
cess in performing intestinal anastomosis when compared 
to centuries ago, the results have never been perfect.1 Anas-
tomotic dehiscence (AD) is the most feared complication in 
intestinal surgical procedures and can cause serious conse-
quences to patients, from reoperations to need for stoma cre-
ation, pelvic sepsis and deaths from various causes.2  
In colorectal operations, depending on the location of the 
anastomosis, the incidence of dehiscence may vary from 1 to 
24%.2 When symptomatic, they are associated with mortality 
in 6 to 22% of cases.3
The integrity of the anastomosis results from a complex 
interaction between the surgeon, the patient and the under-
lying disease.1 Although the accurate prediction of risk is im-
possible, certain factors related to the patient, such as age, 
male gender, smoking, hypoalbuminemia, corticosteroid use, 
ASA (American Society of Anesthesiology) statuses  III and 
IV are related to AD. Elements related to the surgical proce-
dure itself (tension at the anastomosis site, blood supply, pro-
longed surgery) and the intestinal condition (inflammatory 
disease, distal neoplasia, metastases, peritonitis) also play a 
key role for successful healing of anastomoses.1,4,5 
Stapled anastomoses have gained more room in the last 
30 years, with the introduction of new disposable staplers. 
Even with good acceptance in the current scenario, recent 
studies have failed to demonstrate the superiority of this 
technique when compared with hand-sewn anastomosis in 
colorectal surgeries.6-9 Although some studies have reported 
a higher rate of stenosis,7 low anastomoses performed by 
stapling seem to technically facilitate the procedure and re-
duce surgical time, especially in patients with a narrow pel-
vis. The decision regarding the technique should be based 
on the surgeon’s expertise, clinical circumstances and the 
availability of staplers.7
Several materials have been proposed to obtain internal 
or external anastomosis reinforcement, aiming to reduce the 
risk of dehiscence and/or minimize its consequences. Intra-
luminal sealants,5,10 biodegradable material compounds with 
barrier function, aim to prevent the contact of the fecal con-
tents with the anastomosis, thereby avoiding the extravasa-
tion of fecal matter in the case of AD.5,11 A prospective, multi-
center, randomized controlled trial is in progress to evaluate 
the effectiveness of this device.11 
Extraluminal sealants function as an external coating of 
the anastomosis and have been proposed aiming to fill the 
gaps between the staples/stitches, reduce bleeding and the 
rate of AD (extravasation).10 This method can be particularly 
valuable for anastomosis of high risk, as in the case of some 
degree of AD, the defect would be sealed by the coated ma-
terial, thereby preventing the clinical outcome.12 Included in 
this group are multiple devices, such as fibrin glue, expand-
able polytetrafluoroethylene (ePTFE), oxidized regenerated 
cellulose (Curacelp), platelet-rich plasma, the omentum, hy-
aluronic acid/carboxymethyl cellulose and collagen matrix-
bound coagulation factors, also called human fibrinogen and 
thrombin patch (HFTP - TachoSilp).10
Most studies performed with these materials are experi-
mental models in animals and have not shown convincing 
results.12,13 Evidence of efficacy and safety through prospec-
tive, controlled and randomized trials are scarce.10,12,13 Fi-
brin sealants are the most often studied of these materials, 
showing positive results in humans, although without sta-
tistical significance.14
The HFTP (TachoSilp) is an equine collagen sponge coated 
with human thrombin and fibrinogen, primarily developed 
for secondary hemostasis. Thrombin converts fibrinogen 
into fibrin, thereby creating a fibrin clot. This clot maintains 
the collagen sponge firmly adhered to the tissue, which 
provides an extra layer of sealing.12 Its usefulness, efficacy 
and safety have been demonstrated in some studies, for 
different types of procedures, from liver and heart surgery 
and transplants to abdominal and urological procedures.15
When used to protect high-risk intestinal anastomoses, 
it seems to have a beneficial effect in the prevention of AD, 
although most of these results were obtained from experi-
mental studies.16,17 
Clinical data on the use of HFTP - Tachosil ® in these 
anastomoses is limited. In one of the few studies carried 
out in humans, De Stefano et al.,18 in a nonrandomized trial, 
described the use of this device in 24 patients undergoing 
conventional colorectal operations. The use of the product 
was considered effective as a sealant of anastomoses in 
these patients, assessed by the shorter hospital stay com-
pared to the control group (7.2 × 9.3 days). 
In spite of advances in surgical technology and all anas-
tomosis creation and protection mechanisms, the occur-
rence of AD after procedures in the colon and especially 
the rectum9 continues to show unacceptably high frequen-
cies.2 For this reason, it is necessary to develop new tech-
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niques, products and studies that demonstrate the real 
benefit of the available devices, as the currently endorsed 
mechanisms have not been able to reduce this important 
complication.
The aim of this article was to describe in details the tech-
nique of HFTP - TachoSil ® use as an extraluminal protec-
tive device in intestinal anastomoses, showing preliminary 
results in four patients submitted to surgical procedures, 
with varying diagnoses and clinical conditions. 
Technical description 
To use HFTP as an extraluminal protection device in intestinal 
anastomoses, the surgical steps to perform the latter should 
occur without any changes in the usual technical standards 
in their respective topographies. The anastomoses can be per-
formed manually or mechanically, according to the surgeon’s 
experience and preference and the local conditions of the 
segments to be anastomosed. This protection strategy can be 
used in both anastomoses performed through conventional 
or laparoscopic surgery.
Thereafter, the device is removed from its sterile packag-
ing and sectioned into pieces of determined sizes accord-
ing to the type of anastomosis to be protected (Fig. 1A). The 
original size of the product is 9.5 × 4.8 cm, with a rectangular 
aspect. The active surface of the product, which triggers the 
coagulation that results in the sealing of the anastomotic site, 
has a yellowish color due to its riboflavin coverage used only 
as a marker. 
On the back table, the membrane fragments are washed in 
a container with approximately 20 mL of isotonic saline solu-
tion at 0.9% for several seconds (Fig. 1B). From this point on, 
with the active yellowish surface in contact with the anasto-
mosed segment, the membrane segments are adapted around 
the anastomosis and gently compressed with gauze wrapped 
in a surgical glove for 3-5 minutes (Fig. 1C). There can be over-
lapping of the product segments without any detrimental ef-
fects. After this time, the soft compression is removed and 
a firm clot adhered to the applied segment can be observed, 
and then the anastomosis surrounded by the product is re-
viewed. One should emphasize the need for coverage of about 
1 to 2 cm on each side of the anastomosis for proper adhesion 
of the membrane to the intestine and sealing of the sutured 
segment (Fig. 1D).
All types of anastomoses of the small and large intes-
tine (entero-enteric, entero-colic, colo-colic, ileo-rectal and 
colorectal) can be protected with HFTP.
Preliminary results 
According to the previously described technical principles, 
four patients that underwent intestinal anastomoses were 
submitted to the use of HFTP for extraluminal reinforce-
ment and comprised the preliminary sample of this techni-
cal description study. Two female patients were operated for 
colorectal neoplasms (left colon) and underwent convention-
al colectomy. One male patient was operated for an anasto-
motic fistula secondary to right ileocolectomy due to previous 
complicated appendectomy, being submitted to a new ileo-
colic resection, also conventionally. Finally, a female patient 
with enteral fistula and previous peritoneostomy underwent 
enteroanastomosis for fistula closure. The details of each pa-
tient are given in Table 1 and in Figs. 2, 3 and 4.
As it can be observed, two patients underwent hand-sewn 
anastomosis and two were submitted to stapled anastomo-
ses. Patient 1 underwent high colorectal stapled anastomo-
sis at the level of the sacral promontory and HFTP was ap-
plied after the use of the stapler, without removing the latter. 
This technical detail allows better fitting when applying the 
device. The stapler was removed only after the complete ad-
hesion of the membrane. Patient 2 underwent a colo-colic 
end-to-end hand-sewn anastomosis, and the membrane was 
applied without difficulty (Fig. 2). Patient 3 underwent an 
entero-enteral anastomosis in an area of  enteral fistula sec-
ondary to previous complex abdominal surgery. After primary 
suture with 3.0 polypropylene yarn, HFTP was applied with a 
closed bandage over the fistula (Fig. 3). These first 3 patients 
recovered uneventfully postoperatively without any general 
complications or complications at the anastomotic site.
Patient 4 received the HFTP after an ileo-transverse anas-
tomosis performed by the side-to-side technique with a 100-
mm linear stapler. Although the technical conditions of the 
anastomosis were the best possible (Fig. 4), the patient devel-
oped AD and abdominal abscess, underwent reoperation with 
externalization of the two anastomotic mouths on the right 
flank (Mikulicz stoma) and died due to acute bacterial endo-
carditis and heart failure.
Discussion
In the year 2013, the anastomoses performed on the small 
intestine, colon and especially on the rectum still show sig-
Fig. 1 – Technical description of HFTP use for intestinal 
anastomosis protection. A, The membrane is cut at varying 
sizes to better fit the anastomotic site. B, Exposure to 
isotonic saline solution to trigger the membrane’s clotting 
properties. C, Compression with dressing protected by 
surgical glove for 3-5 minutes. D, Final appearance of the 
anastomosis protected by the membrane. 
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nificant rates of dehiscence. In recent years, developments 
in the field of colorectal surgery were mainly concentrated in 
staplers and disposable equipment mainly for laparoscopic 
techniques. Despite significant advances in this area, AD is 
found in a significant proportion of patients. Its consequences 
include reoperations, longer hospital stay and consequent in-
crease in treatment costs, as well as the possibility of mortal-
ity.1 Therefore, any technology or device aimed at reducing AD 
will have an impact on the outcome after these procedures.
Colorectal anastomoses by compression (Valtrac ™ ring, 
magnetic rings, AKA-2™, endoluminal compression ring − 
endoCAR™, anastomotic compression clip − CAR) have also 
been studied and although they appear to be safe, they do not 
show superiority to hand-sewn or stapled anastomosis when 
AD rates are compared.9
Products designed to seal anastomotic sites are classified 
as intraluminal and extraluminal. HFTP (TachoSil ®) is among 
the latter, used for secondary hemostasis mainly in  liver sur-
gery. In recent years, some publications have demonstrated 
the safety and feasibility of using this device in digestive 
anastomoses. 
Pantelis et al.16 evaluated the use of HFTP in rats for high-
risk anastomoses (with only 4 separated absorbable suture 
points), compared to traditional anastomoses (with 8 sepa-
rate absorbable suture points). The experiment showed that 
the use of the product in high-risk anastomoses resulted 
in lower mortality and dehiscence rates when compared to 
anastomotic procedures without the sealing mechanism.
Parker et al.10 described the feasibility of applying HFTP in 
24 patients undergoing anterior resection of the rectum. The 
product was well tolerated in procedures performed by lapa-
Table 1 – Baseline characteristics of the four patients submitted to procedures with intestinal anastomoses and extra-
luminal use of HFTP - TachoSil®.
Patient Gender Age (years) Procedure Type of 
anastomosis
Diagnosis Postoperative 
complications 
#1 F 59 Anterior rectal resection Stapled Neoplasia No
#2 F 67 Left segmental colectomy Hand-sewn Neoplasia No
#3 F 43 Enteroanastomosis Hand-sewn Enteral fistula with 
peritoneotomy
No
#4 M 41 Right ileocolectomy Stapled Enteral fistula Yes (anastomosis 
dehiscence)
F, female; M, male.
Fig. 4 – Final aspect of the functional termino-terminal 
ileo-transverse anastomosis in patient 4. In spite of the 
perfect technical condition and adequate protection with 
HFTP membrane, there was evolution to anastomotic 
dehiscence and death.
Fig. 3 – Final aspect of patient 3 after enteroanastomosis 
for enteric fistula closure in peritoneotomy area with HFTP 
protection.
Fig. 2 – Final aspect of the anastomosis in patient 2 after 
protection with HFTP.
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roscopic and conventional techniques, with no significant 
adverse effects. According to the authors, the use of HFTP 
seems to be facilitated by the use of circular staplers, except 
in male patients with a narrow pelvis. In our initial series 
of cases, the membrane was used only in conventional pro-
cedures, despite the possibility of using it with the laparo-
scopic approach.
The use of products for anastomosis protection may also 
be indicated in attempts to close enteral fistulae. There are 
scarce data in the literature regarding this indication, but 
the rational use of this strategy in high-risk patients with 
bad nutritional status represents the possibility of future 
studies. In our preliminary series of 4 patients, we used the 
HFTP in a patient with enteral fistula and peritoneotomy 
with good results.
Evidently, the use of products and devices such as HFTP 
does not replace adequate surgical technique and the basic 
principles for AD prevention, such as adequate blood supply 
in the anastomosed segment, no tension and good local con-
ditions. Furthermore, the use of these alternative techniques 
is no guarantee of a healed anastomosis, as seen in patient 4 
of this preliminary series. Even with the use of HFTP, dehis-
cence can occur, with consequent mortality.
The cost of these devices must also be considered. The 
routine use of products such as HFTP is not recommended, 
as anastomoses on the small and large intestine have been 
performed over the past 50 years with high success rates. 
However, it is believed that patients with elevated risk of 
AD, such as those with deficient nutritional status, prior ra-
diotherapy in the case of the anastomoses on the rectum and 
inflammatory bowel disease with previous use of corticoids, 
for instance, can benefit from this type of strategy here de-
scribed. Randomized and controlled studies, with significant 
sample of patients, are required for more extensive conclu-
sions regarding the actual role of anastomosis protection de-
vices such as the HFTP.  
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